Viibryd Package Insert

No view

VIIBRYD. VIIBRYD vilazodone HCl Tablets for oral administration. Initial U.S. Approval: 2011. WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS. See full prescribing The efficacy of VIIBRYD was established in two 8-week, placebo-controlled trials in adult Product protected by U.S. Patent No. 5,532,241 and .Learn about VIIBRYD, and how it may help you manage your condition. See risk info, including Boxed Warning full Prescribing Information..VIIBRYD have not been established in pediatric patients [see Warnings and Precautions 5.1 , and Use in Specific Populations. 8.4 ]. 1 VIIBRYD vilazodone HCl tablets are supplied in the following configurations: Tablet. Strength. Tablet. Color/Shape. Tablet. Markings. Package. Configuration. NDC Code. 10 mg..Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Viibryd Vilazodone .